Proton beam radiotherapy of uveal melanoma: Italian patients treated in Nice, France

European Journal of Ophthalmology

Volumn 19, Issue 4, 2009, Pages 654-660

  Mosci, Carlo ^a   Mosci, Sofia ^b   Barla, Annalisa ^b   Squarcia, Sandro ^b   Chauvel, Pierre ^c   Iborra, Nicole ^c  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c CENTRE ANTOINE LACASSAGNE   (France)

Author keywords

Intraocular melanoma; Proton beam; Radiotherapy

Indexed keywords

ADULT; ARTICLE; CANCER CONTROL; CANCER RECURRENCE; CANCER RELAPSE; ENUCLEATION; FEMALE; FRANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTON THERAPY; RISK FACTOR; SURVIVAL RATE; TUMOR VOLUME; UVEA MELANOMA;

EYE ENUCLEATION; FEMALE; FOLLOW-UP STUDIES; FRANCE; HUMANS; ITALY; MALE; MELANOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROPORTIONAL HAZARDS MODELS; PROTONS; RADIOTHERAPY, HIGH-ENERGY; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME; UVEAL NEOPLASMS;

EID: 70549098087     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210901900421     Document Type: Article

References (29)

1. Scotto J, Fraumeni JF Jr, Lee JA. Melanomas of the eye and other noncutaneous sites: epidemiologic aspects. J Natl Cancer Inst 1976; 56: 489-91.
2. Shields CL, Shields JA, Cater J, et al. Plaque radiotherapy for uveal melanoma: long-term visual outcomes in 1106 consecutive patients. Arch Ophthalmol 2000; 118: 1219-28.
3. Melia BM, Abramson DH, Albert DM, et al. Collaborative Ocular Melanoma Study (COMS) randomized trial of I-125 brachytherapy for medium choroidal melanoma. Visual acuity after 3 years, COMS report no. 16. Ophthalmology 2001; 108: 348-66.
4. Gragoudas ES. Proton beam irradiation of uveal melanomas: the first 30 years. The Weisenfeld Lecture. Invest Ophthalmol Vis Sci 2006; 47: 4666-73.
5. Damato BE, Paul J, Foulds WS. Risk factors for metastatic uveal melanoma after transscleral local resection. Br J Ophthalmol 1996; 80: 109-16.
6. Jampol LM, Moy CS, Murray TG, et al. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: IV. Local treatment failure and enucleation in the first 5 years after brachytherapy, COMS report no. 19. Ophthalmology 2002; 109: 2197-206.
7. Vitale V, Scolaro T, Andreucci L, et al. The proton radiotherapy of melanoma of the uvea. The technic, methodology and first clinical observations. Radiol Med (Torino) 1992; 84: 630-5.
8. Ravazzoni L, Mosci C, Polizzi A, Schenone M, Soldati MR, Buono C. Ultrasonographic follow-up of patients with choroidal melanoma following conservative treatment. Ophthalmologica 1998; 212 (Suppl 1): 77-8.
9. Engl HW, Hanke M, Neubauer A. Regularization of Inverse Problems. Dordrecht: Kluwer Academic Publishers; 1996.
10. Hastie T, Tibshirani R, Friedman J. The Elements of Statistical Learning. New York: Springer-Verlag; 2001.
11. Barla A, Mosci S, Rosasco L, Verri A. A method for robust variable selection with significance assessment. Proceedings of ESANN 2008; Bruges, Belgium.
12. Poggio T, Smale S. The mathematics of learning: dealing with data. N Am Math Soc 2003; 50: 537-44.
13. Egger E, Zografos L, Schalenbourg A, et al. Eye retention after proton beam radiotherapy for uveal melanoma. Int J Radiat Oncol Biol Phys 2003; 55: 867-80.
14. Egger E, Schalenbourg A, Zografos L, et al. Maximizing local tumor control and survival after proton beam radiotherapy of uveal melanoma. Int J Radiat Oncol Biol Phys 2001; 51: 138-47.
15. Gragoudas ES, Lane AM. Uveal melanoma: proton beam irradiation. Ophthalmol Clin North Am 2005; 18: 111-8.
16. Damato B, Kacperek A, Chopra M, Campbell IR, Errington RD. Proton beam radiotherapy of choroidal melanoma: the Liverpool-Clatterbridge experience. Int J Radiat Oncol Biol Phys 2005; 62: 1405-11.
17. Dendale R, Lumbroso-Le Rouic L, Noel G, et al. Proton beam radiotherapy for uveal melanoma: results of Curie Institut-Orsay proton therapy center (ICPO). Int J Radiat Oncol Biol Phys 2006; 65: 780-7.
18. Seddon JM, Gragoudas ES, Egan KM, et al. Relative survival rates after alternative therapies for uveal melanoma. Ophthalmology 1990; 97: 769-77.
19. Char DH, Quivey JM, Castro JR, Kroll S, Phillips T. Helium ions versus iodine 125 brachytherapy in the management of uveal melanoma. A prospective, randomized, dynamically balanced trial. Ophthalmology 1993; 100: 1547-54.
20. Courdi A, Caujolle JP, Grange JD, et al. Results of proton therapy of uveal melanomas treated in Nice. Int J Radiat Oncol Biol Phys 1999; 45: 5-11.
21. Li W, Gragoudas ES, Egan KM. Metastatic melanoma death rates by anatomic site after proton beam irradiation for uveal melanoma. Arch Ophthalmol 2000; 118: 1066-70.
22. Gragoudas ES, Lane AM, Munzenrider J, Egan KM, Wenjum L. Long-term risk of local failure after proton therapy for choroidal/ciliary body melanoma. Trans Am Ophthalmol Soc 2002; 100: 43-50.
23. Rummelt V, Folberg R, Woolson RF, Hwang T, Pe'er J. Relation between the microcirculation architecture and the aggressive behavior of ciliary body melanomas. Ophthalmology 1995; 102: 844-51.
24. Blasi MA, Roccella F, Balestrazzi E, et al. 3p13 region: a possible location of a tumor suppressor gene involved in uveal melanoma. Cancer Genet Cytogenet 1999; 108: 81-3.
25. Aalto Y, Eriksson L, Seregard S, Larsson O, Knuutila S. Concomitant loss of chromosome 3 and whole arm losses and gains of chromosome 1, 6, or 8 in metastasizing primary uveal melanoma. Invest Ophthalmol Vis Sci 2001; 42: 313-7.
26. Midena E, Bonaldi L, Parrozzani R, Tebaldi E, Boccassini B, Vujosevic S. In vivo detection of monosomy 3 in eyes with medium-sized uveal melanoma using transscleral fine needle aspiration biopsy. Eur J Ophthalmol 2006; 16: 422-5.
27. Maat W, Ly LV, Jordanova ES, de Wolff-Rouendaal D, Schalij-Delfos NE, Jager MJ. Monosomy of chromosome 3 and an inflammatory phenotype occur together in uveal melanoma. Invest Ophthalmol Vis Sci 2008; 49: 505-10.
28. Withers HR. Biological basis of radiation therapy for cancer. Lancet 1992; 339: 156-9.
29. Suit H, Urie M. Proton beams in radiation therapy. J Natl Cancer Inst 1992; 84: 155-9.